## Management of Esophageal Variceal Bleeding: Secondary Prevention ### Acute Phase Management The patient has received appropriate acute management: resuscitation, blood products, and endoscopic variceal ligation (EVL), which is the gold standard endoscopic therapy for actively bleeding esophageal varices (Harrison's Principles of Internal Medicine, 21e, Ch. 297). ### Secondary Prevention: The Evidence-Based Standard **Key Point:** After successful control of acute variceal bleeding with EVL, the cornerstone of **secondary prophylaxis** (prevention of rebleeding) is the combination of **non-selective beta-blockers (NSBBs) + repeat EVL sessions**. However, when asked for the single "most appropriate next step to prevent rebleeding," pharmacotherapy with a non-selective beta-blocker (propranolol or nadolol) is initiated **immediately** after hemostasis is achieved — often within 24–48 hours of the acute bleed. **High-Yield (AASLD / Baveno VII Guidelines):** - **Non-selective beta-blockers** (propranolol, nadolol, or carvedilol) reduce portal pressure and are the pharmacological backbone of secondary prophylaxis - **Repeat EVL** is scheduled at 2–4 week intervals until variceal eradication, but this is a planned procedural series — not the immediate "next step" in the context of preventing rebleeding - The combination of NSBB + EVL is superior to either alone for secondary prevention ### Why Propranolol (Option B) is Correct 1. **Immediate initiation:** NSBBs are started as soon as the patient is hemodynamically stable, making them the most appropriate *next step* after acute EVL 2. **Mechanism:** Reduces cardiac output (β1) and causes splanchnic vasoconstriction (β2), lowering portal pressure and variceal wall tension 3. **Evidence base:** Multiple RCTs and meta-analyses confirm NSBBs reduce rebleeding rates by ~40–50% compared to no treatment 4. **Guidelines:** AASLD and Baveno VII both recommend NSBB initiation as part of secondary prophylaxis immediately following acute variceal hemorrhage ### Why Repeat EVL at 1–2 Weeks (Option A) is Incorrect as the "Next Step" - Repeat EVL sessions are part of the eradication protocol and are scheduled at **2–4 week intervals**, not 1–2 weeks per current guidelines - More importantly, EVL alone (without pharmacotherapy) is inferior to combination therapy; pharmacotherapy is initiated first and concurrently - The question asks for the "next step to prevent rebleeding" — pharmacotherapy is initiated immediately, whereas repeat endoscopy is a scheduled follow-up procedure ### Role of TIPS (Option C) **Clinical Pearl:** TIPS is reserved for: - Rebleeding despite combined EVL + pharmacotherapy (rescue therapy) - Acute variceal bleeding uncontrolled by endoscopic + pharmacological therapy - High-risk patients (Child-Pugh C or HVPG >20 mmHg) — early pre-emptive TIPS within 72 hours - **NOT** routine first-line secondary prevention in a patient who responded to EVL ### Role of Spironolactone (Option D) Spironolactone is a diuretic used for management of ascites and does not reduce portal pressure sufficiently to prevent variceal rebleeding. It is not indicated as secondary prophylaxis for varices. | Intervention | Indication | Timing | |---|---|---| | EVL (acute session) | Active variceal bleeding | Emergency | | **Propranolol (NSBB)** | **Secondary prophylaxis** | **Immediately after stabilization** | | Repeat EVL sessions | Variceal eradication | Every 2–4 weeks until eradication | | TIPS | Refractory rebleeding / rescue | After failure of EVL + NSBB | | Spironolactone | Ascites management | Chronic management | **Key Point:** Per Harrison's and Baveno VII guidelines, non-selective beta-blockers are initiated as the immediate pharmacological next step after acute variceal bleeding is controlled, making propranolol the most appropriate answer for secondary prevention of rebleeding.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.